Gurlek F, Tasdemir E. Is it an advantage or disadvantage to usage angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in COVID-19 patients?. Int J Res Med Sci [Internet]. 2020 Nov. 27 [cited 2025 Oct. 14];8(12):4200-5. Available from: https://www.msjonline.org/index.php/ijrms/article/view/8883